comparemela.com

Latest Breaking News On - David barthel - Page 1 : comparemela.com

Marizyme Inc CEO releases corporate update including details of key progress on DuraGraft

Marizyme Inc (OTCQB:MRZM) CEO David Barthel joined Steve Darling from Proactive to provide an exciting update on the remarkable progress that the company.

David-barthel
Drug-administration
Marizyme-inc
Steve-darling
Coronary-artery-bypass-grafting

Marizyme CEO Delivers Business Update

Marizyme, Inc. Marizyme CEO Delivers Business Update 23-Oct-2023 / 15:00 CET/CEST The issuer is solely responsible for the content of this announcement. Marizyme CEO.

Italy
United-states
Austria
United-kingdom
David-barthel
Harrison-ross
European-union
Marizyme-inc
Drug-administration
Chief-executive-officer
Coronary-artery-bypass-grafting
Securities-litigation-reform-act

Marizyme, Inc. Announces FDA Clearance for Flagship Product, DuraGraft™

Marizyme, Inc. Marizyme, Inc. Announces FDA Clearance for Flagship Product, DuraGraft™ 06-Oct-2023 / 15:00 CET/CEST The issuer is solely responsible for the content of this announcement. Marizyme, Inc. Announces FDA Clearance for Flagship Product, DuraGraft™   DuraGraft is the first and only FDA.

Argentina
Mexico
United-states
India
South-africa
Australia
Harrison-ross
David-barthel
Drug-administration
Marizyme-inc
Exchange-commission
News-service

vimarsana © 2020. All Rights Reserved.